0 XP   0   0   0

Genprex Inc










Financial Health of Genprex




Comparing to competitors in the Biotechnology industry




  Industry Rankings  


Genprex Inc
Buy, Hold or Sell?

Should you buy, hold or sell Genprex?

I guess you are interested in Genprex Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Genprex

Let's start. I'm going to help you getting a better view of Genprex Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Genprex Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Genprex Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Genprex Inc. The closing price on 2022-12-02 was $1.32 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Genprex Inc Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Genprex Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Genprex earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Genprex to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genprex Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM--281.7%+281.7%
YOY--344.8%+344.8%
5Y--450.1%+450.1%
10Y--541.0%+541.0%
1.1.2. Return on Assets

Shows how efficient Genprex is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genprex to the Biotechnology industry mean.
  • -15.0% Return on Assets means that Genprex generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genprex Inc:

  • The MRQ is -15.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.0%TTM-12.5%-2.4%
TTM-12.5%YOY-12.4%-0.2%
TTM-12.5%5Y-31.6%+19.1%
5Y-31.6%10Y-69.8%+38.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.0%-9.9%-5.1%
TTM-12.5%-8.9%-3.6%
YOY-12.4%-9.3%-3.1%
5Y-31.6%-11.7%-19.9%
10Y-69.8%-12.7%-57.1%
1.1.3. Return on Equity

Shows how efficient Genprex is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genprex to the Biotechnology industry mean.
  • -15.9% Return on Equity means Genprex generated $-0.16 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genprex Inc:

  • The MRQ is -15.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -13.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.9%TTM-13.2%-2.8%
TTM-13.2%YOY-12.6%-0.6%
TTM-13.2%5Y-45.6%+32.4%
5Y-45.6%10Y-83.5%+38.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.9%-12.0%-3.9%
TTM-13.2%-11.5%-1.7%
YOY-12.6%-10.8%-1.8%
5Y-45.6%-14.2%-31.4%
10Y-83.5%-15.2%-68.3%

1.2. Operating Efficiency of Genprex Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Genprex is operating .

  • Measures how much profit Genprex makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genprex to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genprex Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM--271.0%+271.0%
YOY--325.9%+325.9%
5Y--454.0%+454.0%
10Y--537.1%+537.1%
1.2.2. Operating Ratio

Measures how efficient Genprex is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Genprex Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
YOY-3.604-3.604
5Y-5.132-5.132
10Y-6.371-6.371

1.3. Liquidity of Genprex Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Genprex is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 14.35 means the company has $14.35 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Genprex Inc:

  • The MRQ is 14.347. The company is very able to pay all its short-term debts. +2
  • The TTM is 23.323. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ14.347TTM23.323-8.976
TTM23.323YOY64.149-40.826
TTM23.3235Y30.617-7.294
5Y30.61710Y23.767+6.851
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3475.117+9.230
TTM23.3235.755+17.568
YOY64.1495.854+58.295
5Y30.6176.511+24.106
10Y23.7676.222+17.545
1.3.2. Quick Ratio

Measures if Genprex is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genprex to the Biotechnology industry mean.
  • A Quick Ratio of 13.95 means the company can pay off $13.95 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genprex Inc:

  • The MRQ is 13.953. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 22.247. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ13.953TTM22.247-8.294
TTM22.247YOY58.906-36.659
TTM22.2475Y28.382-6.134
5Y28.38210Y21.518+6.864
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.9534.284+9.669
TTM22.2474.664+17.583
YOY58.9064.787+54.119
5Y28.3825.218+23.164
10Y21.5185.182+16.336

1.4. Solvency of Genprex Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Genprex assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genprex to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.06 means that Genprex assets are financed with 6.2% credit (debt) and the remaining percentage (100% - 6.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Genprex Inc:

  • The MRQ is 0.062. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.046. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.062TTM0.046+0.016
TTM0.046YOY0.016+0.030
TTM0.0465Y0.108-0.062
5Y0.10810Y0.104+0.004
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0620.278-0.216
TTM0.0460.277-0.231
YOY0.0160.306-0.290
5Y0.1080.367-0.259
10Y0.1040.403-0.299
1.4.2. Debt to Equity Ratio

Measures if Genprex is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genprex to the Biotechnology industry mean.
  • A Debt to Equity ratio of 6.6% means that company has $0.07 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genprex Inc:

  • The MRQ is 0.066. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.049. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.066TTM0.049+0.018
TTM0.049YOY0.016+0.032
TTM0.0495Y0.214-0.165
5Y0.21410Y0.186+0.027
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0660.315-0.249
TTM0.0490.317-0.268
YOY0.0160.319-0.303
5Y0.2140.403-0.189
10Y0.1860.462-0.276

2. Market Valuation of Genprex Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Genprex generates.

  • Above 15 is considered overpriced but always compare Genprex to the Biotechnology industry mean.
  • A PE ratio of -12.91 means the investor is paying $-12.91 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genprex Inc:

  • The EOD is -12.262. Company is losing money. -2
  • The MRQ is -12.912. Company is losing money. -2
  • The TTM is -20.096. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-12.262MRQ-12.912+0.650
MRQ-12.912TTM-20.096+7.183
TTM-20.096YOY-42.127+22.032
TTM-20.0965Y-41.432+21.336
5Y-41.43210Y-30.690-10.742
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-12.262-8.986-3.276
MRQ-12.912-9.792-3.120
TTM-20.096-16.243-3.853
YOY-42.127-20.876-21.251
5Y-41.432-16.665-24.767
10Y-30.690-14.732-15.958
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Genprex.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Genprex Inc:

  • The MRQ is -120.668. Very Bad. -2
  • The TTM is 587.145. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ-120.668TTM587.145-707.813
TTM587.145YOY20.026+567.119
TTM587.1455Y145.245+441.900
5Y145.24510Y145.2450.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-120.668-0.032-120.636
TTM587.1450.004+587.141
YOY20.0260.016+20.010
5Y145.2450.006+145.239
10Y145.2450.003+145.242

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Genprex is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.06 means the investor is paying $2.06 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Genprex Inc:

  • The EOD is 1.956. Good. +1
  • The MRQ is 2.059. Good. +1
  • The TTM is 2.341. Good. +1
Trends
Current periodCompared to+/- 
EOD1.956MRQ2.059-0.104
MRQ2.059TTM2.341-0.282
TTM2.341YOY5.237-2.896
TTM2.3415Y32.453-30.112
5Y32.45310Y24.039+8.414
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.9561.835+0.121
MRQ2.0592.006+0.053
TTM2.3412.774-0.433
YOY5.2373.453+1.784
5Y32.4532.713+29.740
10Y24.0392.402+21.637
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Genprex Inc.

3.1. Institutions holding Genprex Inc

Institutions are holding 9.221% of the shares of Genprex Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30Vanguard Group Inc3.80030.00011824935127380.7029
2022-06-30Geode Capital Management, LLC0.89960.0001431976175834.2431
2022-06-30UBS Group AG0.56590.0002271766-385-0.1415
2022-06-30Group One Trading, LP0.3280.0003157522-57130-26.6152
2022-06-30State Street Corporation0.27020129739-460-0.3533
2022-06-30Millennium Management LLC0.26860.0001128962-85546-39.8801
2022-06-30Cypress Capital, LLC0.20820.020210000000
2022-06-30VERUS CAPITAL PARTNERS, LLC0.18640.02438950040004.6784
2022-06-30T. Rowe Price Associates, Inc.0.167408040033004.2802
2022-06-30Northern Trust Corp0.157075401-3290-4.1809
2022-06-30Silvercrest Asset Management Group LLC0.11660.00065600000
2022-06-30IHT Wealth Management, LLC0.10910.00645237500
2022-06-30Staley Capital Advisers Inc0.10410.00415000000
2022-06-30Spire Wealth Management0.09370.00264500000
2022-06-30Susquehanna International Group, LLP0.0837040181401810
2022-06-30StoneX Group Inc0.07320.02513515000
2022-06-30HighTower Advisors, LLC0.06680.00013207920900186.9577
2022-06-30Charles Schwab Investment Management Inc0.061902974200
2022-06-30Virtu Financial LLC0.06190.003529710906943.9368
2022-06-30Dimensional Fund Advisors, Inc.0.047202264419609.4759
Total 7.66980.08773683082-37080-1.0%

3.2. Funds holding Genprex Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-10-31Vanguard Total Stock Mkt Idx Inv2.34840.0001112769400
2022-09-30Vanguard Instl Ttl Stck Mkt Idx Tr2.34840.000211276946220.0552
2022-10-31Vanguard Extended Market Index Investor1.24520.00159792800
2022-09-30Fidelity® Extended Market Index0.52510.001325216600
2022-10-31iShares Micro-Cap ETF0.20310.01459752700
2022-06-30BlackRock Extended Mkt Composite0.1590.000976335763350
2022-09-30Fidelity® Total Market Index0.14180.00026808800
2022-09-30BlackRock Extended Equity Market K0.14040.000967399-621-0.913
2022-09-30EC SICAV EverCapital Invms UCITS I Ins I0.12490.97586000000
2022-09-30AST T. Rowe Price Growth Opps0.11430.005254900-12900-19.0265
2022-10-31Vanguard Balanced Index Inv0.11290.00025420000
2022-09-30Fidelity® Series Total Market Index0.08890.00014268600
2022-09-30NT Ext Equity Mkt Idx Fd - NL0.08430.00124050100
2022-09-30Fidelity® NASDAQ Composite Index®0.07320.00053515600
2022-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.0680.0012326584361.3531
2022-10-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.06680.00023210100
2022-09-30Northern Trust Extended Eq Market Idx0.06220.0012985100
2022-09-30NT Ext Equity Mkt Idx Fd - L0.06220.0012985100
2022-09-30Schwab Total Stock Market Index0.06190.00032974200
2022-09-30Spartan Total Market Index Pool E0.03450.00011658500
Total 8.06551.00593873062+63872+1.6%

3.3. Insider Transactions

Insiders are holding 1.343% of the shares of Genprex Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 
2019-09-05John Rodney VarnerBUY18000.89 

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Genprex Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.096-0.080-17%0.121-180%0.033-392%0.025-484%
Book Value Growth---0.142-0.102-28%0.130-210%-0.035-75%-0.031-78%
Book Value Per Share--0.6750.812-17%0.791-15%0.428+58%0.321+110%
Book Value Per Share Growth---0.142-0.102-28%0.130-210%-0.035-75%-0.031-78%
Current Ratio--14.34723.323-38%64.149-78%30.617-53%23.767-40%
Debt To Asset Ratio--0.0620.046+35%0.016+290%0.108-42%0.104-40%
Debt To Equity Ratio--0.0660.049+36%0.016+309%0.214-69%0.186-64%
Dividend Per Share----0%-0%-0%-0%
Eps---0.108-0.104-3%-0.096-11%-0.079-26%-0.064-40%
Eps Growth--0.107-0.034+132%0.135-21%0.331-68%0.331-68%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1.956-5%2.0592.341-12%5.237-61%32.453-94%24.039-91%
Pe Ratio-12.262+5%-12.912-20.096+56%-42.127+226%-41.432+221%-30.690+138%
Peg Ratio---120.668587.145-121%20.026-703%145.245-183%145.245-183%
Price Per Share1.320-5%1.3901.910-27%3.793-63%2.401-42%1.778-22%
Price To Total Gains Ratio-13.740+5%-14.469-26.815+85%-32.063+122%-35.072+142%-35.072+142%
Profit Growth--10.701-3.389+132%13.511-21%9.106+18%18.740-43%
Quick Ratio--13.95322.247-37%58.906-76%28.382-51%21.518-35%
Return On Assets---0.150-0.125-16%-0.124-17%-0.316+111%-0.698+367%
Return On Equity---0.159-0.132-17%-0.126-21%-0.456+186%-0.835+424%
Total Gains Per Share---0.096-0.080-17%0.121-180%0.033-392%0.025-484%
Total Gains Per Share Growth---0.078-0.107+37%-1.927+2362%-2.319+2863%-2.068+2544%
Usd Book Value--32411285.00038969542.250-17%37999898.750-15%20560907.300+58%15419410.778+110%
Usd Book Value Change Per Share---0.096-0.080-17%0.121-180%0.033-392%0.025-484%
Usd Book Value Per Share--0.6750.812-17%0.791-15%0.428+58%0.321+110%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.108-0.104-3%-0.096-11%-0.079-26%-0.064-40%
Usd Price Per Share1.320-5%1.3901.910-27%3.793-63%2.401-42%1.778-22%
Usd Profit---5169326.000-5002900.750-3%-4619772.000-11%-3706614.250-28%-3009875.704-42%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.096-0.080-17%0.121-180%0.033-392%0.025-484%
 EOD+3 -2MRQTTM+7 -20YOY+5 -225Y+13 -1410Y+12 -15

4.2. Fundamental Score

Let's check the fundamental score of Genprex Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-12.262
Price to Book Ratio (EOD)Between0-11.956
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than113.953
Current Ratio (MRQ)Greater than114.347
Debt to Asset Ratio (MRQ)Less than10.062
Debt to Equity Ratio (MRQ)Less than10.066
Return on Equity (MRQ)Greater than0.15-0.159
Return on Assets (MRQ)Greater than0.05-0.150
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Genprex Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.330
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets34,565
Total Liabilities2,154
Total Stockholder Equity32,411
 As reported
Total Liabilities 2,154
Total Stockholder Equity+ 32,411
Total Assets = 34,565

Assets

Total Assets34,565
Total Current Assets30,901
Long-term Assets30,901
Total Current Assets
Cash And Cash Equivalents 30,053
Other Current Assets 848
Total Current Assets  (as reported)30,901
Total Current Assets  (calculated)30,901
+/-0
Long-term Assets
Property Plant Equipment 35
Intangible Assets 666
Other Assets 2,963
Long-term Assets  (as reported)3,664
Long-term Assets  (calculated)3,664
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,154
Long-term Liabilities0
Total Stockholder Equity32,411
Total Current Liabilities
Accounts payable 683
Other Current Liabilities 1,471
Total Current Liabilities  (as reported)2,154
Total Current Liabilities  (calculated)2,154
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock48
Retained Earnings -88,910
Capital Surplus 121,273
Total Stockholder Equity (as reported)32,411
Total Stockholder Equity (calculated)32,411
+/-0
Other
Capital Stock48
Cash and Short Term Investments 30,053
Common Stock Shares Outstanding 47,893
Common Stock Total Equity48
Liabilities and Stockholders Equity 34,565
Net Debt -30,053
Net Invested Capital 32,411
Net Tangible Assets 31,745
Net Working Capital 28,747



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
> Total Assets 
410
0
0
0
1,911
1,277
1,008
1,267
1,267
1,260
12,891
11,049
9,269
9,269
6,264
4,068
3,534
24,640
24,749
23,352
31,367
51,036
48,731
46,327
42,862
39,409
34,565
34,56539,40942,86246,32748,73151,03631,36723,35224,74924,6403,5344,0686,2649,2699,26911,04912,8911,2601,2671,2671,0081,2771,911000410
   > Total Current Assets 
250
0
0
0
1,639
954
496
401
401
194
12,540
10,689
8,847
8,847
5,802
3,609
2,977
24,032
24,158
22,711
30,715
50,378
48,062
45,645
39,140
35,703
30,901
30,90135,70339,14045,64548,06250,37830,71522,71124,15824,0322,9773,6095,8028,8478,84710,68912,5401944014014969541,639000250
       Cash And Cash Equivalents 
234
0
0
0
1,602
930
468
374
374
161
12,002
10,310
8,601
8,601
4,497
2,548
2,002
23,080
22,127
21,058
27,320
47,069
44,243
42,021
38,629
34,555
30,053
30,05334,55538,62942,02144,24347,06927,32021,05822,12723,0802,0022,5484,4978,6018,60110,31012,0021613743744689301,602000234
       Net Receivables 
0
0
0
0
8
0
0
0
9
9
0
9
9
9
11
0
1
1
0
0
0
0
0
0
0
32
0
03200000001101199909900080000
       Other Current Assets 
16
0
0
0
37
24
28
27
23
23
539
370
237
237
1,295
259
172
70
1,136
966
385
201
756
749
511
1,116
848
8481,1165117497562013859661,136701722591,29523723737053923232728243700016
   > Long-term Assets 
0
0
0
0
272
322
512
866
866
1,066
351
360
422
422
462
459
558
608
592
641
652
659
670
682
3,722
3,706
3,664
3,6643,7063,7226826706596526415926085584594624224223603511,0668668665123222720000
       Property Plant Equipment 
1
0
0
0
5
7
10
9
8
8
14
16
24
24
24
24
45
51
46
42
39
37
39
44
49
42
35
354249443937394246514524242424161488910750001
       Goodwill 
0
0
0
0
0
0
0
560
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000005600000000
       Intangible Assets 
156
0
0
0
241
261
277
297
297
299
323
326
379
379
421
424
491
536
535
588
602
611
620
627
642
644
666
666644642627620611602588535536491424421379379326323299297297277261241000156
       Long-term Assets Other 
0
0
0
0
26
54
225
560
1,058
760
13
18
398
18
16
12
22
22
11
11
11
11
11
11
3,673
3,020
2,963
2,9633,0203,673111111111111222212161839818137601,05856022554260000
> Total Liabilities 
16
0
0
0
286
170
210
395
395
831
301
565
388
388
939
537
511
697
240
376
451
614
1,047
1,162
1,585
2,385
2,154
2,1542,3851,5851,1621,04761445137624069751153793938838856530183139539521017028600016
   > Total Current Liabilities 
16
0
0
0
286
170
210
395
395
831
301
565
388
388
939
537
511
697
240
376
451
614
1,047
1,162
1,585
2,385
2,154
2,1542,3851,5851,1621,04761445137624069751153793938838856530183139539521017028600016
       Short-term Debt 
0
0
0
0
0
0
0
0
0
279
0
0
0
25
61
62
74
0
0
0
0
0
0
0
0
0
0
000000000074626125000279000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
279
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000279000000000
       Accounts payable 
16
0
0
0
286
139
168
363
629
1,149
301
565
295
206
877
475
436
638
182
321
193
339
370
592
973
1,253
683
6831,2539735923703391933211826384364758772062955653011,14962936316813928600016
       Other Current Liabilities 
0
0
0
0
286
170
210
395
202
831
301
565
93
388
939
537
511
697
240
54
258
614
677
570
612
1,132
1,471
1,4711,13261257067761425854240697511537939388935653018312023952101702860000
   > Long-term Liabilities 000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
26
0
225
560
760
1,012
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000001,0127605602250260000
> Total Stockholder Equity
394
0
0
0
1,625
1,107
798
872
429
429
12,590
10,484
8,881
8,881
5,325
3,531
3,024
23,943
24,510
22,976
30,916
50,423
47,684
45,165
41,277
37,025
32,411
32,41137,02541,27745,16547,68450,42330,91622,97624,51023,9433,0243,5315,3258,8818,88110,48412,5904294298727981,1071,625000394
   Common Stock
0
0
0
0
0
0
0
0
12
12
14
15
15
15
16
16
19
33
39
39
43
47
48
48
48
48
48
4848484848474339393319161615151514121200000000
   Retained Earnings Total Equity-88,910000-68,898-64,912-58,422-53,194-50,419-46,046-40,479-38,054-35,679-31,984-29,825-26,394-24,208-18,146-17,452-16,7860000000
   Accumulated Other Comprehensive Income 000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
17,656
17,869
18,093
36,784
36,863
38,691
39,213
40,988
41,570
43,484
69,956
74,890
76,130
89,296
115,287
116,535
0
0
0
121,273
121,273000116,535115,28789,29676,13074,89069,95643,48441,57040,98839,21338,69136,86336,78418,09317,86917,6560000000
   Treasury Stock000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
15,761
15,995
16,867
17,656
0
17,869
36,784
36,863
0
38,691
40,988
41,570
43,484
69,956
74,890
76,130
89,296
115,287
116,535
117,453
119,247
120,717
121,273
121,273120,717119,247117,453116,535115,28789,29676,13074,89069,95643,48441,57040,98838,691036,86336,78417,869017,65616,86715,99515,7610000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-19,578
Operating Income-19,601-19,578
 
Operating Expense (+$)
Research Development8,608
Selling General Administrative10,970
Selling And Marketing Expenses-
Operating Expense19,57819,578
 
Net Interest Income (+$)
Interest Income5
Interest Expense-0
Net Interest Income55
 
Pretax Income (+$)
Operating Income-19,601
Net Interest Income5
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-19,596-19,606
EBIT - interestExpense = 0
-19,596
-19,596
Interest Expense0
Earnings Before Interest and Taxes (ebit)0-19,596
Earnings Before Interest and Taxes (ebitda)23
 
After tax Income (+$)
Income Before Tax-19,596
Tax Provision--
Net Income From Continuing Ops-19,596-19,596
Net Income-19,596
Net Income Applicable To Common Shares-19,596
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses19,601
Total Other Income/Expenses Net5-5
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ZAL.XETRA
now

I found you a STOCH Bearish Reversal Divergence on the daily chart of ZAL.XETRA.

ZAL.XETRA Daily Candlestick Chart
LOTA.V
now

I found you a STOCH Bearish Hidden Divergence on the daily chart of LOTA.V.

LOTA.V Daily Candlestick Chart
SPTE.LSE
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SPTE.LSE.

SPTE.LSE Daily Candlestick Chart
SHP1.LSE
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SHP1.LSE.

SHP1.LSE Daily Candlestick Chart
PLTS.LSE
2 minutes ago

I found you a Death Cross on the daily chart of PLTS.LSE.

PLTS.LSE Daily Candlestick Chart
PDD.LSE
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PDD.LSE.

PDD.LSE Daily Candlestick Chart
NRJL.LSE
2 minutes ago

I found you a Death Cross on the daily chart of NRJL.LSE.

NRJL.LSE Daily Candlestick Chart
IEEU.LSE
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IEEU.LSE.

IEEU.LSE Daily Candlestick Chart
EUSR.LSE
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of EUSR.LSE.

EUSR.LSE Daily Candlestick Chart
APEX.LSE
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of APEX.LSE.

APEX.LSE Daily Candlestick Chart
3SRR.LSE
5 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of 3SRR.LSE.

3SRR.LSE Daily Candlestick Chart
3SHE.LSE
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 3SHE.LSE.

3SHE.LSE Daily Candlestick Chart
CO2P.LSE
8 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CO2P.LSE.

CO2P.LSE Daily Candlestick Chart
K3C.LSE
10 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of K3C.LSE.

K3C.LSE Daily Candlestick Chart
PBEE.LSE
12 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PBEE.LSE.

PBEE.LSE Daily Candlestick Chart
BIOM.LSE
14 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of BIOM.LSE.

BIOM.LSE Daily Candlestick Chart
IGAS.LSE
16 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IGAS.LSE.

IGAS.LSE Daily Candlestick Chart
FOUR.LSE
16 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FOUR.LSE.

FOUR.LSE Daily Candlestick Chart
GOODYEAR.NSE
16 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GOODYEAR.NSE.

GOODYEAR.NSE Daily Candlestick Chart
LQDH.LSE
19 minutes ago

I found you a Golden Cross on the daily chart of LQDH.LSE.

LQDH.LSE Daily Candlestick Chart
LSIL.LSE
19 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LSIL.LSE.

LSIL.LSE Daily Candlestick Chart
W7L.LSE
22 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of W7L.LSE.

W7L.LSE Daily Candlestick Chart
SCF.LSE
24 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SCF.LSE.

SCF.LSE Daily Candlestick Chart
KHANDSE.BSE
32 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of KHANDSE.BSE.

KHANDSE.BSE Daily Candlestick Chart